Aurora Spine Corp Total Liabilities
Aurora Spine Corp total liabilities. Based on the latest financial reports, Aurora Spine Corp (ASG) has total liabilities worth CA$6.11 Million CAD (≈ $4.42 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Aurora Spine Corp (ASG) liquidity interval to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Aurora Spine Corp (2012–2025)
Total liabilities of Aurora Spine Corp from 2012 to 2025. This chart illustrates how Aurora Spine Corp's total liabilities have evolved over time, based on quarterly financial data.
Aurora Spine Corp Competitors by Total Liabilities
The table below lists competitors of Aurora Spine Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
OSR Holdings Inc
NASDAQ:OSRH
|
USA | $41.71 Million |
|
Processa Pharmaceuticals Inc
NASDAQ:PCSA
|
USA | $1.98 Million |
|
Bloomsbury Publishing Plc
LSE:BMY
|
UK | GBX148.60 Million |
|
SARAMA RESOURCES LTD
F:48S1
|
Germany | €1.95 Million |
|
Foresight Group Holdings Limited
LSE:FSG
|
UK | GBX79.08 Million |
|
Xylo Technologies Ltd.
NASDAQ:XYLO
|
USA | $19.96 Million |
|
Saxlund Group AB
ST:SAXG
|
Sweden | Skr75.97 Million |
|
EXPLOITS DISCOVERY CORP.
F:634
|
Germany | €320.26K |
Liability Composition Analysis (2012–2025)
This chart breaks down Aurora Spine Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Aurora Spine Corp total assets.
Liquidity & Leverage Metrics
Aurora Spine Corp Total Liabilities Ratios Explained
Aurora Spine Corp total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.25 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.16 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.68 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Aurora Spine Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Aurora Spine Corp (2012–2025)
The table below shows the annual total liabilities of Aurora Spine Corp from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CA$6.59 Million ≈ $4.77 Million |
-0.98% |
| 2024-12-31 | CA$6.66 Million ≈ $4.82 Million |
-0.42% |
| 2023-12-31 | CA$6.69 Million ≈ $4.84 Million |
+15.19% |
| 2022-12-31 | CA$5.81 Million ≈ $4.20 Million |
+16.25% |
| 2021-12-31 | CA$4.99 Million ≈ $3.61 Million |
+28.92% |
| 2020-12-31 | CA$3.87 Million ≈ $2.80 Million |
-21.03% |
| 2019-12-31 | CA$4.91 Million ≈ $3.55 Million |
+26.27% |
| 2018-12-31 | CA$3.88 Million ≈ $2.81 Million |
+6.81% |
| 2017-12-31 | CA$3.64 Million ≈ $2.63 Million |
+1.79% |
| 2016-12-31 | CA$3.57 Million ≈ $2.58 Million |
+8.54% |
| 2015-12-31 | CA$3.29 Million ≈ $2.38 Million |
-29.00% |
| 2014-12-31 | CA$4.64 Million ≈ $3.35 Million |
+337.03% |
| 2013-12-31 | CA$1.06 Million ≈ $767.44K |
+361.27% |
| 2012-12-31 | CA$230.00K ≈ $166.38K |
-- |
About Aurora Spine Corp
Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. The company offers interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTR, ZIP LP, and ZIP-51 for patients suffering from degenerative disc diseases. It also provides SOLO, an anterior lumbar inter… Read more